Distribution of Estimated 10-Year Risk of Recurrent Vascular Events and Residual Risk in a Secondary Prevention PopulationLotte Kaasenbrood, Frank L.J. Visseren, Jan Westerink et al.|Circulation|2016Cited by 275
Development and validation of a prediction rule for recurrent vascular events based on a cohort study of patients with arterial disease: the SMART risk scoreJohannes A N Dorresteijn, Frank L.J. Visseren, Annemarie M.J. Wassink et al.|Heart|2013Cited by 265
Low-grade inflammation as a risk factor for cardiovascular events and all-cause mortality in patients with type 2 diabetesShahnam Sharif, Hendrik M. Nathoe, Yolanda van der Graaf et al.|Cardiovascular Diabetology|2021Cited by 204
Effect of Repetitive Intra-Arterial Infusion of Bone Marrow Mononuclear Cells in Patients With No-Option Limb IschemiaMartin Teraa, Marianne C. Verhaar, Ralf W. Sprengers et al.|Circulation|2015Cited by 181
CETP genotype predicts increased mortality in statin-treated men with proven cardiovascular disease: an adverse pharmacogenetic interactionJakub J. Regieli, Pieter A. Doevendans, D. E. Grobbee et al.|European Heart Journal|2008Cited by 101